Israel Englander Equillium, Inc. Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.48 - $0.74 $23,717 - $36,564	-49,412 Reduced 66.68%	24,692 $17,000
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.79 $41,490 - $66,892	-84,674 Reduced 53.33%	74,104 $55,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.24 $88,915 - $196,884	158,778 New	158,778 $116,000
Q2 2021 Aug 16, 2021	SELL	$5.11 - $7.64 $321,991 - $481,411	-63,012 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.03 - $10.5 $255,202 - $532,728	50,736 Added 413.29%	63,012 $451,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $42,720 - $80,776	12,276 New	12,276 $66,000
Q3 2020 Nov 16, 2020	SELL	$2.78 - $26.5 $65,785 - $627,096	-23,664 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.34 - $3.53 $16,967 - $25,596	-7,251 Reduced 23.45%	23,664 $70,000
Q1 2020 May 14, 2020	SELL	$2.3 - $5.5 $4,669 - $11,165	-2,030 Reduced 6.16%	30,915 $84,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $5.0 $64,671 - $107,785	-21,557 Reduced 39.55%	32,945 $111,000
Q3 2019 Nov 14, 2019	SELL	$3.31 - $5.6 $110,117 - $186,300	-33,268 Reduced 37.9%	54,502 $207,000
Q2 2019 Aug 15, 2019	SELL	$5.28 - $8.2 $255,979 - $397,544	-48,481 Reduced 35.58%	87,770 $497,000
Q2 2019 Aug 14, 2019	BUY	$5.28 - $8.2 $719,405 - $1.12 Million	136,251 New	136,251 $996,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.